Top

Published in:

01-08-2023 | Vulgar Psoriasis | Epidemiology clinical study

Risankizumab-related serious ARs in patients with psoriasis

Published in: Reactions Weekly | Issue 1/2023

Excerpt

This postmarketing analysis generally confirms the known safety profile of risankizumab in patients with psoriasis or psoriatic arthritis, and provides more information on risankizumab-related cancer, say authors of a study published in Pharmaceutics. …

Calapai F, et al. Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database Pharmaceutics : 11 Jul 2023. Available from: URL: https://doi.org/10.3390/pharmaceutics15071933

Title: Risankizumab-related serious ARs in patients with psoriasis
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Vulgar Psoriasis
Psoriatic Arthritis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44175-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Risankizumab-related serious ARs in patients with psoriasis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Heparin

Moxifloxacin

Antiepileptics

Bbibp-corv

Antineoplastics

Apixaban